|
Canada-0-LABORATORIES कंपनी निर्देशिकाएँ
|
कंपनी समाचार :
- Our Leadership - Baxter
Our forward-looking leadership team is made up of dedicated, focused and experienced executives Working with each other and with our employees worldwide, their knowledge and experience come together to make a difference for all our stakeholders – patients, healthcare providers, employees, investors and communities around the globe
- Baxter Appoints Andrew Hider Chief Executive Officer
Baxter International Inc (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors
- Andrew Hider | Baxter
Andrew Hider is president and chief executive officer of Baxter International Inc , and a member of the Baxter Board Hider assumed his current responsibilities at Baxter in August 2025
- Baxter Announces CEO Retirement and Appointment of COO
Baxter International Inc (NYSE:BAX), a global medtech leader, today announced that José (Joe) E Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately He will serve in an advisory capacity through Oct 31, 2025
- Baxter Announces CEO Retirement and Appointment of COO
DEERFIELD, Ill -- (BUSINESS WIRE)-- Baxter International Inc (NYSE:BAX), a global medtech leader, today announced that José (Joe) E Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately He will serve in an advisory capacity through Oct 31, 2025 The Baxter Board of Directors has appointed lead independent
- Brent Shafer - Baxter
Brent Shafer has served as Baxter's Non-Executive Chair since August 2025 and has served as a director of Baxter since May 2022 Shafer served as lead independent director from April 2023 to February 2025, prior to his appointment as Interim CEO and Chair of the Board from February 2025 to August 2025
- Baxter Reports Third-Quarter 2025 Results | Baxter
Baxter International Inc (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025 "I joined Baxter because it's a global healthcare leader – an iconic brand with an essential portfolio that touches more than 350 million patients every year," said Andrew Hider, president and CEO
- Baxter - Baxter Names José Almeida Chairman and CEO
DEERFIELD, Ill , October 28, 2015 – The board of directors of Baxter International (NYSE: BAX) today announced it has named José (Joe) Almeida the company's Chairman and Chief Executive Officer (CEO), effective January 1, 2016 Almeida will join the company immediately as an executive officer to facilitate a smooth leadership transition Almeida, 53, will succeed Robert L Parkinson, Jr
- Uniting to Save and Sustain Lives | Baxter
Bringing our Purpose to Life Our mission to save and sustain lives is reflected in our business priorities and our commitment to be an agent of change at a global level This means doing what is right for our planet, our patients and customers, our teams and our communities We put this commitment into action through high-impact philanthropy, diversity, equity and inclusion, nurturing
- Baxter Names Chris Toth CEO of Proposed Kidney Care Spinoff
Baxter International Inc (NYSE:BAX), a global medtech leader, today announced it has selected Chris Toth to be chief executive officer (CEO) of the company’s planned spinoff of its Renal Care and Acute Therapies businesses Until the spinoff, which remains subject to satisfaction of customary conditions and is currently expected to occur by July 2024 or earlier, Mr Toth will serve as
|
|